MedPath

A comparative study of the effect of vaginal and pessary progesterone along with the vaginal progesterone in preventing preterm delivery in twin pregnancies of pregnant wome

Phase 4
Recruiting
Conditions
preterm Delivery.
Sequelae of complication of pregnancy, childbirth, and the puerperium
Registration Number
IRCT20151207025420N2
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
100
Inclusion Criteria

Twin pregnancies
Pregnancy age 16-18 weeks
The cervical length less than 25 mm

Exclusion Criteria

Twin-Twin Transfusion Syndrome
monoamniotic twins
Rupture of the membranes
The presence of a major or chromosomal abnormality in at least one fetus
Women who have cervical cerclage in their current pregnancy
Placenta Previa
Progesterone treatment before inclusion
Progesterone sensitivity
Severe liver defect
Porphyria
Otosclerosis
Major depression
Taking drugs that interfere with the effect of progesterone

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath